PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's disease (Q34154766)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

Nichols NF

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Cimini MG

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Haas JV

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Staton BA

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Tedroff J

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Svensson KA

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

817-824

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Early L-dopa treatment initially retards but later enhances dopamine receptor supersensitivity following unilateral dopamine denervation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

(-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Levodopa-induced dyskinesia: review, observations, and speculations

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Coadministration of (-)-OSU6162 with l-DOPA normalizes preproenkephalin mRNA expression in the sensorimotor striatum of primates with unilateral 6-OHDA lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900144-2

7 January 2021

Identifiers

10.1016/S0028-3908(02)00144-2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34154766&oldid=2050755548"